These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37167127)

  • 1. [Effectiveness of empirical
    Bordin DS; Voynovan IN; Sarsenbaeva AS; Zaytsev OV; Abdulkhakov RA; Bakulina NV; Bakulin IG; Osipenko MF; Livzan MA; Alekseenko SA; Tarasova LV; Tarasova GN; Bogomolov PO; Maev IV; Andreev DN; Abdulkhakov SR; Starostin BD; Bakanova NV; Kononova AG; Kolbasnikov SV; Bueverova EL; Moreira L; Megraud F; O'Morain C; Perez Nyssen O; Gisbert J
    Ter Arkh; 2023 Mar; 95(2):120-129. PubMed ID: 37167127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan].
    Abdulkhakov SR; Bordin DS; Abdulkhakov RA; Safina DD; Gizdatullina AR; Gimadieva LZ; Safina GM; Ziyatdinov AI; Maturina AM; Nyssen OP; Megraud F; O'Morain C; Perez-Gisbert J
    Ter Arkh; 2020 Sep; 92(8):52-59. PubMed ID: 33346462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
    Milivojevic V; Babic I; Kekic D; Rankovic I; Sagdati S; Panic N; Spasic IS; Krstic M; Milosavljevic T; Moreira L; Nyssen OP; Mégraud F; O' Morain C; Gisbert J
    Dig Dis; 2023; 41(3):377-386. PubMed ID: 37253341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Nyssen OP; Vaira D; Pérez Aísa Á; Rodrigo L; Castro-Fernandez M; Jonaitis L; Tepes B; Vologzhanina L; Caldas M; Lanas A; Lucendo AJ; Bujanda L; Ortuño J; Barrio J; Huguet JM; Voynovan I; Lasala JP; Sarsenbaeva AS; Fernandez-Salazar L; Molina-Infante J; Jurecic NB; Areia M; Gasbarrini A; Kupčinskas J; Bordin D; Marcos-Pinto R; Lerang F; Leja M; Buzas GM; Niv Y; Rokkas T; Phull P; Smith S; Shvets O; Venerito M; Milivojevic V; Simsek I; Lamy V; Bytzer P; Boyanova L; Kunovský L; Beglinger C; Doulberis M; Marlicz W; Goldis A; Tonkić A; Capelle L; Puig I; Megraud F; Morain CO; Gisbert JP;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2243-2257. PubMed ID: 34954341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management.
    Huguet JM; Ferrer-Barceló L; Suárez P; Barcelo-Cerda S; Sempere J; Saracino IM; Fiorini G; Vaira D; Pérez-Aísa Á; Jonaitis L; Tepes B; Castro-Fernandez M; Pabón-Carrasco M; Keco-Huerga A; Voynovan I; Lucendo AJ; Lanas Á; Martínez-Domínguez SJ; Alfaro Almajano E; Rodrigo L; Vologzanina L; Bordin DS; Gasbarrini A; Babayeva G; Lerang F; Leja M; Kupčinskas J; Rokkas T; Marcos-Pinto R; Meštrović A; Gridnyev O; Phull PS; Smith SM; Boltin D; Buzás GM; Kral J; Şimşek H; Matysiak-Budnik T; Milivojevic V; Marlicz W; Venerito M; Boyanova L; Doulberis M; Capelle LG; Cano-Català A; Moreira L; Nyssen OP; Mégraud F; O'Morain C; Gisbert JP;
    United European Gastroenterol J; 2024 Jul; 12(6):691-704. PubMed ID: 38685613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management.
    Gatta L; Nyssen OP; Fiorini G; Saracino IM; Pavoni M; Romano M; Gravina AG; Granata L; Pellicano R; Gasbarrini A; Di Leo A; Losurdo G; Franceschi F; Nardone G; Rocco A; Dore MP; Farinati F; Ghisa M; Bellini M; Holton J; Puig I; Vaira D; Borghi C; Mégraud F; O'Morain C; Gisbert JP
    United European Gastroenterol J; 2023 Feb; 11(1):103-113. PubMed ID: 36565017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Registry on
    Nyssen OP; Bordin D; Tepes B; Pérez-Aisa Á; Vaira D; Caldas M; Bujanda L; Castro-Fernandez M; Lerang F; Leja M; Rodrigo L; Rokkas T; Kupcinskas L; Pérez-Lasala J; Jonaitis L; Shvets O; Gasbarrini A; Simsek H; Axon ATR; Buzás G; Machado JC; Niv Y; Boyanova L; Goldis A; Lamy V; Tonkic A; Przytulski K; Beglinger C; Venerito M; Bytzer P; Capelle L; Milosavljević T; Milivojevic V; Veijola L; Molina-Infante J; Vologzhanina L; Fadeenko G; Ariño I; Fiorini G; Garre A; Garrido J; F Pérez C; Puig I; Heluwaert F; Megraud F; O'Morain C; Gisbert JP;
    Gut; 2021 Jan; 70(1):40-54. PubMed ID: 32958544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow].
    Bordin DS; Voynovan IN; Embutnieks YV; Nyssen OP; Megraud F; O Morain C; Perez-Gisbert J
    Ter Arkh; 2020 Apr; 92(2):12-18. PubMed ID: 32598712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years].
    Bordin DS; Embutnieks YV; Vologzhanina LG; Ilchishina TA; Voynovan IN; Sarsenbaeva AS; Zaitsev OV; Alekseenko SA; Abdulkhakov RA; Dehnich NN; Osipenko MF; Livzan MA; Tsukanov VV; Burkov SG; Bakulina NV; Plotnikova EY; Tarasova LV; Maev IV; Kucheryavyi YA; Baryshnikova NV; Butov MA; Kolbasnikov SV; Pakhomova AL; Zhestkova TV; Baranovsky AY; Abdulhakov SR; Ageeva EA; Lyalyukova EA; Vasyutin AV; Golubev NN; Savilova IV; Morkovkina LV; Kononova AG; Megraud F; O'Morain C; Ramas M; Nyssen OP; McNicholl AG; Gisbert JP
    Ter Arkh; 2019 Feb; 91(2):16-24. PubMed ID: 32598623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
    Xie Y; Zhu Y; Zhou H; Lu ZF; Yang Z; Shu X; Guo XB; Fan HZ; Tang JH; Zeng XP; Wen JB; Li XQ; He XX; Ma JH; Liu DS; Huang CB; Xu NJ; Wang NR; Lu NH
    World J Gastroenterol; 2014 Aug; 20(32):11415-21. PubMed ID: 25170230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.
    Bordin DS; Embutnieks YV; Vologzhanina LG; Il'chishina TA; Voinovan IN; Sarsenbaeva AS; Alekseenko SA; Zaitsev OV; Abdulkhakov RA; Osipenko MF; Livzan MA; Tsukanov VV; Burkov SG; Bakulina NV; Dekhnich NN; Tarasova LV; Plotnikova EY; Maev IV; Kucheryavyi YA; Baryshnikova NV; Butov MA; Kolbasnikov SV; Pakhomova AL; Zhestkova TV; Baranovskii AY; Abdulkhakov SR; Ageeva EA; Lyalyukova EA; Vasyutin AV; Golubev NN; Savilova IV; Morkovkina LV; Kononova AG; Megraud F; O'Morain C; Ramas M; Nyssen OP; McNicholl AG; Gisbert JP
    Ter Arkh; 2018 Feb; 90(2):35-42. PubMed ID: 30701770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadruple therapy for eradication of Helicobacter pylori.
    Ma HJ; Wang JL
    World J Gastroenterol; 2013 Feb; 19(6):931-5. PubMed ID: 23429422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
    World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
    Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
    World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Registry on Helicobacter pylori management (Hp-EuReg): First-line Therapy in Israel.
    Boltin D; Beniashvili Z; Lahat A; Hirsch J; Nyssen OP; Mégraud F; O'Morain C; Gisbert JP; Niv Y
    Isr Med Assoc J; 2021 Jan; 23(1):38-42. PubMed ID: 33443341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of 14-day amoxicillin and furazolidone-based quadruple rescue regimen for eradication of Helicobacter pylori: a retrospective study].
    Liu X; Cheng H; Gao W; Dong X; Hu F
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):567-71. PubMed ID: 24762682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.
    Chen L; He J; Wang L; Ge Q; Chu H; Chen Y; Chen X; Long Y; Deng Y; He H; Li A; Chen S
    Clin Exp Med; 2018 Nov; 18(4):569-576. PubMed ID: 29876770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of vonoprazan-based rescue therapy for
    Yu J; Lv YM; Yang P; Jiang YZ; Qin XR; Wang XY
    World J Gastroenterol; 2023 May; 29(20):3133-3144. PubMed ID: 37346155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Effectiveness of
    Jonaitis P; Kupcinskas J; Nyssen OP; Puig I; Gisbert JP; Jonaitis L
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.